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Abstract
There has recently been a growing interest in the development of statistical meth-
ods to compare medical costs between treatment groups. When cumulative cost is the
outcome of interest, right-censoring poses the challenge of informative missingness due
to heterogeneity in the rates of cost accumulation across subjects. Existing approaches
seeking to address the challenge of informative cost trajectories typically rely on inverse
probability weighting and target a net “intent-to-treat” effect. However, no approaches
capable of handling time-dependent treatment and confounding in this setting have
been developed to date. A method to estimate the joint causal effect of a treatment
regime on cost would be of value to inform public policy when comparing interventions.
In this paper, we develop a nested g-computation approach to cost analysis in order to
accommodate time-dependent treatment and repeated outcome measures. We demon-
strate that our procedure is reasonably robust to departures from its distributional
assumptions and can provide unique insights into fundamental differences in average
cost across time-dependent treatment regimes.
1 Introduction
Rising medical costs are becoming an increasingly important factor in choosing between
comparably safe and effective drugs or therapies. In a given disease setting, studies to
compare mean cumulative costs across treatment groups are therefore of high value for the
purposes of making informed choices. In the ideal case, such a study would include data on
lifetime medical costs after commencing treatment, though this is typically not realistic due
to time and budget constraints. Prior studies have therefore identified cumulative cost over
some fixed time interval after commencing treatment as a suitable outcome measure.
Even when focusing on costs over some fixed period time, it is highly likely that censoring
will occur in some participants; when participants’ survival times are censored, so too are their
cumulative cost outcomes. Straightforward approaches such as the Kaplan-Meier method and
the Cox Proportional Hazards model, despite their utility when seeking to compare survival
distributions in the presence of right-censoring, are not appropriate when the outcome of
1
ar
X
iv
:1
70
5.
08
74
2v
1 
 [s
tat
.M
E]
  2
4 M
ay
 20
17
interest is cumulative medical cost. Due to the heterogeneous nature of cost accumulation
across subjects, the total cost at the time of censoring is generally not independent of the
theoretical total cost over the fixed time interval of interest, even if the censoring time is itself
completely independent of the time to death or study completion (illustrated in Figure 1).
Analyzing medical cost as a time-to-event measure is therefore a fundamentally false strategy.
To avoid confusion, we use the term informative cost trajectories to refer to this challenge,
and restrict use of the phrase “informative censoring” to refer to survival times. While
informative censoring of the survival times may or may not pose its own set of challenges in
studies involving right-censored medical costs, the problem of informative cost trajectories
necessarily poses a barrier and must always be addressed.
The development of methods to handle incomplete cost data has been of growing interest
in recent years. Lin et al. (1997) proposed an estimator for mean costs, expressed as a sum of
products of the Kaplan-Meier estimator for death/survival and suitable estimators for average
cost within defined time intervals. Bang and Tsiatis (2000) altered this estimator such that
desirable asymptotic properties could be achieved under weaker assumptions, whereby mean
costs are estimated within discrete intervals using inverse probability-of-censoring weights
based on the Kaplan-Meier estimator. This method was then broadened to compare mean
costs across predictors of interest, such as treatment (Lin, 2000; Lin, 2003). Li et al. (2016)
proposed the inclusion of inverse probability-of-treatment weights (IPTW) as one of several
ways to address confounding, and further improved upon existing methods by adopting a
Super-Learner algorithm to accommodate more flexible cost distributions.
Existing approaches to compare costs are based on intent-to-treat (ITT) analyses, identi-
fying the net causal effect of baseline treatment on cost irrespective of any post-baseline mod-
ifications to treatment. However, participants may sometimes switch treatments throughout
the course of a study in a manner related to prior observed treatment toxicity, improvements
in health, changes to insurance, or even prohibitively high prior medical costs. Time-varying
treatment for any of these reasons obscures our ability to directly attribute cost contrasts
to different treatments. Though results from ITT analyses are uniquely equipped to provide
insights into the real-world effectiveness of a treatment or therapy on a clinical outcome,
an approach to estimate population-average causal effects would likely be of great value for
informing policy makers when the outcome is total medical cost.
Another limitation of existing approaches is that they generally presume that the prob-
ability of censoring is not informative of death times, conditional on measured covariates at
baseline. Existing approaches can accommodate, for example, a study with staggered entry in
which the distribution of baseline confounders is related to study enrollment time. They have
not, however, permitted censoring at a given time to be related to cost accumulated up until
that point, or treatment/confounding history. Particularly in the presence of heavy censoring
due to subject withdrawal (non-administrative in nature), strict, untestable assumptions re-
garding the censoring mechanism can be a serious limitation to the interpretability of results.
The goal of this work is to develop an approach to cost analysis that accommodates time-
varying treatment and confounding. G-computation has gained attention as an approach to
compare mean outcomes under multiple hypothetical treatment regimes (Robins, 1986). We
therefore consider this framework as an alternative to existing approaches in order to assess
joint causal effects. As will be made apparent, it will be necessary to modify the standard
g-formula to allow reasonable assumptions regarding censoring and death.
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Figure 1: Illustration of the “informative cost trajectories” phenomenon using a small sim-
ulated data set (N = 15), with one-hundred-day cumulative cost outcomes and independent
censoring and death times; in the upper left panel, observed cost trajectories (solid dark) are
shown until either death/study completion (•) or censoring (×). For censored individuals,
the theoretical remainder of the trajectory to death or study completion is depicted (dashed).
Though the censoring and study completion times are themselves independent (upper right
panel: light circles indicate complete cases, and dark circles indicate censoring), the cost at
censoring is highly correlated with the cost at death (lower panel).
The remainder of this paper is organized as follows. In Section 2, we provide a brief
summary of the standard g-computation procedure (which would be appropriate for cost
analysis in the total absence of censoring and death). In Section 3, we present our nested g-
computation approach in which the g-formula is iteratively applied to repeated cost outcomes.
In Section 4, we empirically compare the nested g-formula to existing approaches and evaluate
the sensitivity of our model to departures from its assumptions. We will conclude with a
discussion of our findings, including study limitations and potential future research directions.
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2 A brief review of g-computation
In this section, we briefly describe how the g-formula could be applied to cost data in the
absence of censoring and death. More specific details are provided by Robins (1986); Daniel
et al. (2013) provide an excellent tutorial on how to implement g-computation.
Let i = 1, . . . , N index independently sampled subjects, and let j = 1, . . . , J index equally
spaced intervals over the time range of interest: 0 ≡ τ0 < · · · < τJ ≡ τ . Let Aj and Lj denote
treatment status and confounders at the start of interval j, respectively, and let Y denote
cumulative cost over the interval [0, τ ]. We use overbars to denote variable history, dropping
subscripts for entire histories (e.g., A¯j = (A1, . . . , Aj), and A¯ = (A1, . . . , AJ)).
We adopt the counterfactual notation of Rubin (1978), extended by Robins (1986). Let
A denote the set of all treatment regimes, and Y a¯ the potential cost under treatment A¯ = a¯
(a¯ ∈ A). Then, E[Y a¯] is the expected cost in the hypothetical case in which everyone receives
treatment A¯ = a¯. Letting L denote all values of L¯, and ¯` ∈ L, the g-formula provides an
expression for E[Y a¯] by standardizing in the appropriate temporal order:
E[Y a¯] =
∫
¯`∈L
E[Y|L¯ = ¯`, A¯ = a¯]
J∏
j=1
fLj |L¯j−1,A¯j−1(`j, ¯`j−1, a¯j−1)d¯`, (1)
where f(·) denotes the density function. This formula relies on the following assumptions:
1. Stable unit treatment value assumption (SUTVA): Y a¯i ⊥ A¯i′ , 1 ≤ i 6= i′ ≤ N (the
potential cost is not influenced by the treatment assignment of others).
2. Consistency: Yi =
∑
a¯∈A¯ Y a¯i 1(A¯i = a¯) for 1 ≤ j ≤ J (the observed cost is equal to the
potential cost under treatment A¯i = a¯).
3. Positivity: 0 < P (Aij = 1|L¯ij, A¯i(j−1)) < 1, 1 ≤ j ≤ J (each potential treatment regime
has nonzero probability of occurrence irrespective of covariate history).
4. Sequentially ignorable treatment assignment: Y a¯i ⊥ Aij|L¯ij, A¯i(j−1), 1 ≤ j ≤ J (condi-
tional on prior variables, treatment is independent of the potential cost).
The process by which the integral in Equation (1) is estimated is known as g-computation.
As it is written, one would typically need to model E[Y|L¯, A¯] and f(Lj|L¯j−1, A¯j−1) in order
to evaluate it. In settings where L contains continuous predictors, it is generally necessary
to parametrically model E[Y|L¯, A¯]. In this instance, Equation (1) can be written as:
E[Y a¯] =
∫
¯`∈L
∫
y∈supp(Y|L¯,A¯)
yfY|L¯,A¯(y, ¯`, a¯)
J∏
j=1
fLj |L¯j−1,A¯j−1(`j, ¯`j−1, a¯j−1)dyd¯`, (2)
where supp(Y|L¯, A¯) = {y : fY|L¯,A¯(y, ¯`, a¯) 6= 0}. Evaluation of this integral typically requires
Monte-Carlo integration, whereby data are repeatedly simulated under estimated model pa-
rameters and then averaged. To compare mean costs, one can plug in comparator hypo-
thetical treatment regimes into the g-formula and define suitable contrasts (e.g., differences)
that characterize joint causal effects. Invoking the Markov assumption (Figure 2) can reduce
computational burden, and the nonparametric bootstrap can be used to conduct inference.
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Figure 2: Illustration of time-dependent treatment and confounding in the setting of no
censoring or death. This figure invokes the Markov assumption that observations from a
single interval depend on the prior interval as opposed to all prior intervals.
3 The nested g-formula for cost estimation
In settings where complete cost data are available on all subjects, the approach described in
Section 2 is valid. When censoring and death events occur, however, the assumptions put
forth in the g-computation framework do not naturally generalize in any apparent way. For
example, it is not reasonable to assume that censoring is completely independent of the cost
outcome, but it is not clear how to formulate a conditional independence assumption on the
basis of observed variables.
In this section, describe how repeated cost measures can be used to formulate reasonable
assumptions regarding censoring and death. We then present the nested g-formula as a way
to estimate marginal mean costs and describe in detail how to implement the associated
nested g-computation procedure.
3.1 Repeated cost measures: Time-updating censoring/death risks
Let Yj denote cost accumulated in interval j, and Y¯
a¯
j the potential cost in interval j under
treatment A¯ = a¯, noting that Y a¯i =
∑J
j=1 Y
a¯
ij . Let Cj denote the indicator of censoring at
the start of interval j, and Dj the indicator of death following interval j. We assume that
Dij = 1⇒ Yij′ = 0 for j < j′ ≤ J (that is, no cost is accumulated after death). In this sense,
subjects who die prior to their censoring times have complete cost data.
The concept of a complete treatment regime is only meaningful when taken in the absence
of censoring; we take this as implicit in our notation, though the mean total coast under
treatment history A¯ = a¯ could be more precisely denoted as E[Y a¯,CJ=0]. In the setting of
repeated cost measures, we update the assumptions listed in Section 2:
1. Stable unit treatment value assumption (SUTVA): Y a¯ij ⊥ A¯i′ , 1 ≤ i 6= i′ ≤ N (the
potential cost history is not influenced by the treatment assignment of others).
2. Sequential consistency: Y¯i =
∑
a¯∈A¯ Y¯
a¯
i 1(A¯i = a¯) for 1 ≤ j ≤ J (the observed cost
history is equal to the potential cost history under treatment A¯i = a¯).
3. Positivity: 0 < P (Aij = 1|L¯ij, A¯i(j−1), Y¯i(j−1)) < 1, 1 ≤ j ≤ J (each potential treatment
regime has nonzero probability of occurrence irrespective of covariate history).
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4. Sequentially ignorable treatment assignment: Y a¯ij ⊥ Aij|L¯ij, A¯i(j−1), Y¯i(j−1), 1 ≤ j ≤ J
(conditional on previously observed variables, treatment status is independent of the
potential costs in each interval).
5. Sequentially ignorable censoring: Y a¯ij ⊥ Cij|L¯ij, A¯ij, Y¯i(j−1), 1 ≤ j ≤ J .
6. Sequentially ignorable death: Y a¯ij ⊥ Di(j−1)|L¯ij, A¯ij, Y¯i(j−1), Ci(j−1), 1 ≤ j ≤ J .
7. Sequentially non-informative censoring: Cij ⊥ Di(j−1)|L¯ij, A¯ij, Y¯ij, 1 ≤ j ≤ J .
We refer to the second assumption as sequential consistency to highlight the use of repeated
outcomes; the consistency assumption expressed in terms of Y a¯ would not be sufficient.
Assumptions 5 and 6 state that conditional on observed variable history, censoring and death
are independent of the potential cost. Assumption 7 essentially states that two individuals
of the same variable history, differing only in their censoring status at the beginning of
an interval, are equally likely to die in that interval. We assume the following temporal
ordering of variables within an interval: (Cj,Lj, Aj, Yj, Dj). Figure 3 depicts time-dependent
treatment and confounding in the setting where repeated cost measures are available.
Figure 3: Illustration of time-dependent treatment and confounding in the setting where
repeated cost measures are available. This figure invokes the Markov assumption that obser-
vations from a single interval depend on the one prior and not on all prior intervals.
3.2 The nested g-formula
We seek to construct a formula for the mean cumulative cost over under some hypothetical
treatment regime, A¯ = a¯. This entails applying the g-formula to variables through each in-
terval to estimate E[Y a¯j ], from which an aggregated mean can be formed by invoking linearity
of expectation: E[Y a¯] = ∑Jj=1 E[Y a¯j ]. Under the assumptions of Section 3.1, we have that
E[Y a¯] =
J∑
j=1
∫∫∫ {
yj
j∏
k=1
fYk|Y¯k−1,C¯k,L¯k,A¯k,D¯k−1(yk, y¯k−1, 0,
¯`
k, a¯k, d¯k−1)
×
j∏
k=1
fDk|D¯k−1,Y¯k,C¯k,L¯k,A¯k(dk, d¯k−1, y¯k, 0,
¯`
k, a¯k)
×
j∏
k=1
fLk|L¯k−1,A¯k−1,D¯k−1,Y¯k−1,C¯k(`k,
¯`
k−1, a¯k−1, d¯k−1, y¯k−1, 0)
}
dd¯jdy¯jd¯`j.
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Appendix A presents the derivation of the nested g-formula. The suppressed limits of
integration are analogous to those in Section 2. By convention, Dk = 1 ⇒ Lk′ = Ak′ =
Yk′ = 0, and Dk′ = 1 for k
′ > k. Writing the densities in the integrand as conditional on
not have been censored is implicit in the sense that these are requirements to be observed.
Without Assumptions 5 through 7, densities could not be expressed on the basis of observed
data. The nested g-formula expresses the total mean cost as the sum of mean interval costs
over each interval. By linearity of expectation, this is equivalent to sequentially iterating the
standard g-formula, treating each repeated outcome as a confounder for future observations.
This novel approach has clear advantages. Challenges surrounding informative censoring
of survival times are addressed by allowing time-updating censoring and death risks according
to observed variables. These assumptions allow for censoring to be handled similarly to
treatment in that censoring values are set to zero in the g-formula. Sequentially conditioning
each cost outcome on cost history helps reconstruct the heterogeneity in cost trajectories,
while allowing subjects to contribute to estimation of marginal means for as long as they
are not censored. Repeated outcome measures have previously been used in the setting
of discrete time-to-event problems in order to evaluate cumulative risk (Taubman et al.,
2009); however, our problem fundamentally differs in that each of the continuous outcomes
sequentially impacts future variables and need not be monotonically increasing.
3.3 Nested g-computation for comparing marginal means
We now describe how the nested g-computation procedure can be applied to estimate (and
in turn, compare) mean costs. We specifically consider the case in which L contains con-
tinuous variables. Then, parametric models would be appropriate for: the cost distribution
(Yj|Ykj−1, C¯j = 0, L¯j, A¯j, D¯j−1 = 0), the death risk (Dj|D¯j−1 = 0, Y¯j, C¯j = 0, L¯j, A¯j), and
the confounder distribution (Lj|L¯j−1, A¯j−1, D¯j−1 = 0, Y¯j−1, C¯j = 0). Under the Markov as-
sumption, one could first estimate baseline parameters. Let θ1 = (α1,β1,γ1) index the
confounder, cost, and death models in the first interval, respectively. The analogous post-
baseline parameters, θ = (α,β,γ), can be estimated using all available post-baseline data.
Maximum partial likelihood is one way to estimate (θ1,θ) from some user-specified score
equations. For example, the cost model score equations would be given by:
N∑
i=1
∂
∂β1
log f(Yi1|Ci1 = 0,Li1, Ai1;β1) = 0;
N∑
i=1
Ji∑
j=2
∂
∂β
log f(Yij|C¯ij = 0,Li(j−1), Ai(j−1), Yi(j−1), Di(j−1) = 0,Lij, Aij;β) = 0,
where Ji denotes the number of observations for subject i. Analogous equations exist for the
confounder and death models. Model specification can be made somewhat complex, although
model selection is not the focus of this paper. Death could be modeled using, for example,
logistic regression, and cost could be modeled using a generalized linear model (GLM). The
normal GLM with an identity link would amount to performing ordinary least squares, al-
though the Inverse Gaussian (Inv-N ) and Gamma distributions may be appropriate when
cost is right-skewed, and are appealing due to their support on the positive real line.
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As described in the setting of the standard g-formula in Section 2, the high-dimensional
integral in the nested g-formula generally does not possess a closed-form expression. Given
estimates (θˆ1, θˆ), a Monte-Carlo procedure to obtain an estimate (say, µˆY a¯) of E[Y a¯] for some
treatment regime of interest is given as follows.
Algorithm 1 Monte-Carlo Integration for Nested G-Formula
1. Set A¯ = a¯. For r = 1, . . . , R (a sufficiently large number of Monte-Carlo iterations),
generate random draws as follows on the basis of estimated model parameters:
• Lr1|αˆ1
• Y r1 |(Lr1, A1 = a1; βˆ1)
• Dr1|(Lr1, A1 = a1, Y r1 ; γˆ1)
• For j = 2, . . . , J
– Lrj |(Lrj−1, Aj−1 = aj−1, Y rj−1, Drj−1 = 0; αˆ)
– Y rj |(Lrj−1, Aj−1 = aj−1, Y rj−1, Drj−1 = 0,Lrj , Aj = aj; βˆ)
– Drj |(Lrj−1, Aj−1 = aj−1, Y rj−1, Drj−1 = 0,Lrj , Aj = aj, Y rj ; γˆ)
• Set Yr =
∑J
j=1 Y
r
j
2. E[Y a¯] can be estimated with µˆY a¯ = R−1
∑R
r=1 Yr.
Importantly, the J expectations that comprise the nested g-formula need not be represented
by J separate Monte-Carlo procedures; complete data can be generated for from which mean
interval costs can be summed. Typically, a study to compare costs targets a contrast (e.g., a
difference) in means. Define ∆ = E[Y a¯]−E[Y a¯′ ] for some comparator treatment regimes. In
turn, ∆̂ = µˆY a¯ − µˆY a¯′ can be estimated by applying Algorithm 1 to a¯ and a¯′.
3.4 The nonparametric bootstrap for inference regarding ∆
There is generally no general closed-form analytic expression to estimate the repeat-sample
variance of ∆̂. The nonparametric bootstrap, commonly implemented in g-computation
procedures, can therefore be used to estimate Var[∆̂]. This procedure is described as follows:
Algorithm 2 The Nonparametric Bootstrap for Estimation of Var[∆̂]
1. For b = 1, . . . , B (a sufficiently large number of bootstrap replicates)
• Form dataset “b” by resampling N subjects with replacement from observed data.
• Obtain estimates (θˆb1, θˆ
b
) on the basis of data set “b”
• Apply Algorithm 1 to A¯ = a¯ and then to A¯ = a¯′ on the basis of (θˆb1, θˆ
b
); take the
difference of the results to obtain the bootstrap realization ∆̂b
2. Compute ∆ = B−1
∑B
b=1 ∆̂b
3. An estimate can be obtained as follows: V̂ar[∆̂] = (B − 1)−1∑Bb=1(∆̂b −∆)2
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Wald-based confidence intervals can be formed on the basis of this variance estimator and
inference can be conducted by comparing the quantity V̂ar[∆̂]−1/2(∆̂−∆0) to the appropriate
quantiles of standard normal distribution for some null value ∆0 (e.g., zero under the null
hypothesis of no difference in total mean cost). Other more sophisticated modifications to the
standard nonparametric bootstrap approach are described by Davison and Hinkley (1997).
4 Simulation studies
In this section, we conduct a number of simulation studies in order to empirically assess
the performance of our nested g-formula for cost estimation. We are specifically interested
in (i) evaluating our approach in terms of bias and variability in the presence of various
forms of censoring, (ii) understanding the sensitivity of our approach to departures from
distributional assumptions on repeated cost, and (iii) comparing the nested g-formula to the
previously developed inverse-weighting approaches.
4.1 General simulation setup
Suppose N = 1,000 subjects, each with a maximum of J = 6 observations. We utilize R =
100,000 Monte-Carlo iterations for the g-formula and B = 100 bootstrap samples to compute
standard errors. We assume a binary treatment. In all cases, we invoke Markov assumption
of Figure 3. Let O j = (Lj, Aj, Yj), for ease of notation. To focus attention on the primary
study goals, we hold fixed a number of simulation characteristics.
All participants are presumed not to be censored at the start of the study (C1 = 0).
We generate a single normally distributed time-varying confounder (e.g., some appropriately
transformed propensity score, as per Lu (2005)), This is generated as L1 ∼ N (α0,1, σ2L1) at
baseline, and Lj|(Dj−1 = Cj = 0,O j−1) ∼ N (α0+α1Lj−1+α2Aj−1+α3Yj−1, σ2L) at follow-up.
The odds of treatment “1” in the first interval is given by logit{P (A1 = 1|L1)} = η0,1+η1,1L1,
and at follow-up intervals by
logit{P (Aj = 1|Dj−1 = Cj = 0, Lj−1,O j−1, Lj)} = η0 + η1Lj−1 + η2Lj + η3Aj−1 + η4Yj−1.
We assume comparably safe interventions, so that death is independent of treatment, condi-
tional on prior cost and confounders. The odds of death following the first interval is therefore
given by logit{P (D1 = 1|O1)} = γ0,1 + γ1,1L1 + γ2,1Y1, and the odds of death following each
subsequent interval by
logit{P (Dj = 1|Dj−1 = Cj = 0,O j−1,O j)} = γ0 + γ1Lj−1 + γ2Lj + γ3Yj.
Finally, we assume that the mean cost takes the form µ1 = β0,1 + β1,1L1 + β1,2A1 in the
first interval, and µj = β0 + β1Lj−1 + β2Lj + β3Aj−1 + β4Aj + β5Yj−1 at follow-up intervals,
conditional on Dj−1 = 0 (otherwise, Yj = 0). We will consider different parametric forms for
cost, which we imagine to be in thousands of dollars. In all settings, the target of inference is
given by the joint causal effect, ∆ = E[Y a¯]−E[Y a¯′ ], where a¯ = (1, . . . , 1) and a¯′ = (0, . . . , 0).
All simulations were conducted in R version 3.3.1 (2013). Appendix B provides a table
summarizing the selection of parameters that remain constant across simulations.
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4.2 Results under different censoring mechanisms
The goal of this simulation is to confirm that the nested g-formula provides valid estimates
of ∆ under various forms of censoring. We consider three scenarios, from the least to most
informative. In the first scenario, we assume that censoring occurs completely at random:
P (Cj = 1|Cj−1 = Dj−1 = 0,O j) = 0.05. In the second scenario, we assume staggered
enrollment such that the characteristics of the baseline confounder vary over time:
logit{P (Cj = 1|Cj−1 = Dj−1 = 0,O1)} = −3.3 + 0.25L1 + 0.5A1.
In the third scenario, we assume that the probability of censoring is time-varying, dependent
upon variables in concurrent intervals:
logit{P (Cj = 1|Cj−1 = Dj−1 = 0,O j)} = −3.5 + 0.25Lj + 0.5Aj + 0.01Yj.
In each of these settings, the probability of censoring within each interval is approximately
0.05. We generate cost outcomes from a normal distribution with mean µj (1 ≤ j ≤ J) as
given in Section 4.1, with error variance σ2Y = 2 at each time. Figure 4 illustrates the nature
of the cost trajectories under this setting in the absence of censoring. Under this simulation
setup, the true value of µY 0 ≡ E[Y a¯=0] was determined to be 66.6 and µY 1 ≡ E[Y a¯=1] was
determined to be 72.0 (thus, ∆ = 5.40). Results are depicted in Table 1.
Figure 4: Illustration of simulation setup in the absence of censoring. The gray lines represent
subject specific trajectories, leveling out once death has occurred. The black lines represent
the mean (± one standard deviation) cumulative cost at each observation. The heterogeneity
in trajectories is apparent in this figure, as seen by the increasing variability over time.
The nested g-formula performs well regardless of the censoring mechanism and dependence
on baseline/concurrent variables. Bias is low, the nonparametric bootstrap standard errors
adequately represent the simulation-based standard errors, and two-sided Wald-based 95%
confidence intervals appear to have proper coverage of the true parameter value.
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Table 1: Results from Simulation Study 1 in which a variety of censoring mechanisms are
considered. In this setting, ∆ = 5.40 represents the true value. Depicted are the average bias,
absolute % bias, Monte-Carlo standard error, average bootstrap standard error estimate, and
estimated coverage probability based on Wald-based confidence intervals.
Description Bias(∆̂) % Bias(∆̂) MCSE(∆̂) ŜE(∆̂) CP
Random censoring 0.012 0.227% 0.529 0.543 0.955
Staggered study entry 0.0082 0.152% 0.532 0.542 0.955
Nonrandom dropout 0.0052 0.096% 0.531 0.543 0.949
4.3 Results under various cost distributions
The purpose of this study is to examine the behavior of the nested g-formula under various
parametric models for cost. We consider three different mechanisms to generate cost data,
the first mirroring the prior simulation–namely, Yj ∼ N (µj, σ2Y = 2). We also consider the
two cases in which cost data are right-skewed: namely, Yj ∼ Gamma(α = 8, β = 8/µj) with
mean µj and variance µ
2
j/α, and Yj ∼ Inv-N (µ = µj, λ = 40), with mean µj and variance
µ3j/λ. In each of these settings, the shape parameters (α and λ, respectively) can be estimated
as the inverse of the quasi-likelihood based dispersion factor.
In each of these scenarios, we fit the cost model using each of the three associated GLMs
with the identity link (exactly one of which is correctly specified in each case). We generate
data from the nonrandom dropout mechanism, the most informative among those considered
in the prior study. Results are depicted in Table 2.
Table 2: Results from Simulation Study 2 in which a variety of parametric data generation
mechanisms and models are considered. The true value for the average cumulative costs (and
the difference) differs slightly depending on how the data are generated. Depicted are the
average bias, absolute % bias, simulated standard error, average bootstrap standard error
estimate, and estimated coverage probability based on Wald-based confidence intervals.
Data Generation Mechanism: Normal
Model µY0 µY1 µˆY0 µˆY1 Bias(∆̂) % Bias(∆̂) MCSE(∆̂) ŜE(∆̂) CP
Normal 66.6 72.0 66.6 72.0 0.0052 0.096% 0.531 0.543 0.949
Gamma 66.6 72.0 66.7 72.1 -0.0022 0.040% 0.586 0.556 0.940
Inv-N 66.6 72.0 66.6 72.0 0.0148 0.275% 0.628 0.614 0.932
Data Generation Mechanism: Gamma
Model µY0 µY1 µˆY0 µˆY1 Bias(∆̂) % Bias(∆̂) MCSE(∆̂) ŜE(∆̂) CP
Normal 66.5 71.9 66.5 71.9 0.0070 0.13% 0.948 1.02 0.966
Gamma 66.5 71.9 66.5 71.9 0.0054 0.100% 1.02 1.00 0.950
Inv-N 66.5 71.9 66.5 71.9 -0.0156 0.290% 1.03 1.00 0.938
Data Generation Mechanism: Inverse Gaussian
Model µY0 µY1 µˆY0 µˆY1 Bias(∆̂) % Bias(∆̂) MCSE(∆̂) ŜE(∆̂) CP
Normal 66.1 71.2 66.2 71.5 0.174 3.42% 1.67 1.69 0.959
Gamma 66.1 71.2 66.2 71.3 0.062 1.21% 1.64 1.60 0.940
Inv-N 66.1 71.2 66.1 71.3 0.026 0.502% 1.64 1.57 0.945
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The nested g-formula performs well under correct cost model specification (with low bias,
valid bootstrap standard errors, and proper coverage). When cost is generated from either
the Normal or Gamma distribution, the Inverse Gaussian model results in the highest bias
for estimating ∆. When cost is generated from the Inverse Gaussian distribution, the Normal
model produces the highest bias, and the Gamma model produces slightly less. Given the
heavier skewness of the Inverse Gaussian distribution relative to the others, these findings are
unsurprising. Bootstrap standard errors appear valid regardless of model misspecification.
It could so happen in practice that each mean of interest is estimated with comparable bias
in the same direction, resulting in low bias for the difference. This explains the seemingly fair
performance of the nested g-formula in the third scenario of Table 2 despite misspecification.
We therefore consider a situation in which the cost distribution varies between treatment arms
(a Normal distribution in the control arm an Inverse Gaussian distribution in the treatment
arm). In this case, µY0 = 66.1 and µY1 = 72.0, such that ∆ = 5.92. If the Normal GLM is
used for the cost model in both arms, we find that that µˆY0 = 66.5 and µˆY1 = 71.8, so that
Bias(∆̂) = −0.550 and % Bias(∆̂) = 9.29%, appreciably higher than the bias seen in Table
2. Particular attention should therefore be paid to the parametric assumptions in each arm,
as our target of inference relies on estimation of two quantities.
4.4 Comparison to inverse weighting approaches
We compare the nested g-formula to the confounder-adjusted partitioned estimator (Lin,
2000) and the IPTW approach (Li et al., 2016). Estimation procedures based on these
approaches are outlined in Appendix C. Each of these approaches targets the net effect of
baseline treatment on cumulative cost, whereas the nested g-formula targets the joint causal
effect treatment regime A¯ = 1 relative to A¯ = 0. To highlight this distinction, we denote
the ITT effect by ∆ITT. We compare the average estimates and simulated standard errors
for each approach under the three parametric distributions discussed in Section 4.3. We
consider the settings of random censoring and nonrandom dropout (the former satisfies the
assumptions of existing methods). Results are depicted in Table 3.
Table 3: Results from Simulation 3 in which our nested g-formula is compared to the ap-
proaches of Lin and Li. Depicted are the average estimate and the Monte-Carlo standard
errors.
Nested g-formula Lin (Adjusted) Li (IPTW)
Random censoring ∆̂ MCSE(∆̂) ∆̂ITT MCSE(∆̂ITT) ∆̂ITT MCSE(∆̂ITT)
Normal (∆ = 5.40) 5.41 0.53 2.60 1.15 2.57 1.23
Gamma (∆ = 5.37) 5.35 1.03 2.52 1.42 2.50 1.50
Inv-N (∆ = 5.11) 5.14 1.65 2.26 1.80 2.24 1.88
Nested g-formula Lin (Adjusted) Li (IPTW)
Nonrandom dropout ∆̂ MCSE(∆̂) ∆̂ITT MCSE(∆̂ITT) ∆̂ITT MCSE(∆̂ITT)
Normal (∆ = 5.40) 5.40 0.53 2.47 1.14 2.45 1.22
Gamma (∆ = 5.37) 5.38 1.02 2.38 1.40 2.37 1.48
Inv-N (∆ = 5.11) 5.13 1.64 2.12 1.78 2.11 1.86
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In the setting of random censoring, the ITT estimators do not provide consistent estimates
of ∆, but rather the ITT parameter ∆ITT, which in this setting is much smaller than ∆. The
ITT approaches do not accommodate a time-varying censoring mechanism related to cost,
as seen in that the estimates are attenuated in the setting of nonrandom dropout. Results
from the ITT approaches may therefore provide misleading results about the joint effect of
treatment on cumulative cost if used in the context of time-dependent treatment. Moreover,
the nested g-formula provides markedly smaller standard errors than the ITT approaches,
likely attributable to their complete use of available data. This is not to discredit the merits
of the inverse-weighting approaches in estimating the ITT effect, but rather to illustrate that
a different target of inference translates to a potentially meaningful difference in conclusions.
4.5 Wald tests of the joint causal effect
A test of H0 : ∆ = 0 vs. H1 : ∆ 6= 0 in the context of the nested g-formula is a test of
the joint effect of a treatment regime a¯ on cumulative cost (relative to some comparator
treatment regime a¯′). The joint effect is a simultaneous collection of treatment effects, each
unmediated by treatment assignment history. There are many ways in which data can be
generated under H0, although a simple way would be to set β1,2 = β3 = α2 = 0 in the
context of our simulation setup. In particular, the condition β1,2 = β3 = 0 is insufficient
to generate data from the null, as effects of treatment on cost can be mediated by future
values of the time-varying confounder (leading to a phenomenon known as the g-null paradox,
presented by Robins (1986), and discussed further by Robins and Wasserman (1997)). It is
not straightforward to express a general null hypothesis in terms of the partial likelihood
parameters.
To empirically examine the behavior of the Wald test based on the nonparametric boot-
strap standard errors, we generate data under the null hypothesis for each of the three
parametric models for cost considered. We estimated the level of the Wald-based bootstrap
hypothesis test (at the nominal 5% level) described in Section 3.4. We obtained an estimated
a level of 0.047 under the normal model; under the Gamma and Inverse-Gaussian models,
we obtained estimated levels of 0.048 and 0.051, respectively.
5 Discussion
The challenge of informative cost trajectories poses a major barrier to analyzing cost data
in the presence of censoring, a fact that has been documented and described in multiple
papers (Lin et al., 1997; Bang and Tsiatis, 2000; Lin, 2000; Lin, 2003; Li et al., 2016).
Since time accumulates at the same rate for all individuals, one is not confronted with
this fundamental challenge when the outcome of interest is a true time-to-event measure.
The monotone increasing nature of cost, together with the heterogeneity in cost accrual
rates renders standard approaches for right-censored data invalid. Prior work has primarily
focused on inverse probability weighting in order to address informative cost trajectories in
a way that is consistent with either time-stable treatment or ITT analyses. In this paper, we
have developed an alternative framework to estimate the joint causal effect of a time-varying
treatment on mean cumulative medical costs over some interval of interest.
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Our approach shares a similarity with existing approaches in that a time partition is de-
sirable in some sense. The nested g-formula approach fundamentally differs from the existing
approaches in that the interval partition is the specific means by which reasonable assump-
tions regard censoring can be formed, and the censoring/death risks are time-updating. While
this feature underscores the novelty of our implementation of the g-formula in a broader sense,
the nested g-formula cannot be applied to cost data in the absence of repeated outcomes.
To our knowledge, the g-computation procedure has not been previously used to estimate
parameters involving aggregates of repeated continuous outcomes.
The choice to target either an ITT or a joint causal effect should be scientifically mo-
tivated. The joint treatment effect can be realized as a collection of individual treatment
effects, rather than the net effect of an intention to treat. We argue that the ITT effect is use-
ful for contextualizing real-world contrasts on a subject-specific level, irrespective of events
that occur after treatment commencement. When seeking to make population-level policy
recommendations on the sole basis of differences in average cost at the most fundamental
level, an approach to estimate the joint causal effect would be more appropriate. Such cost
comparisons would be appropriate when presented with treatment options that were compa-
rably safe and effective (or at least, non-inferior in the sense of each not being unacceptably
worse than the other when given additional information such as cost and side-effects).
We have empirically demonstrated that the nested g-formula has favorable finite-sample
properties including low bias, valid bootstrap standard errors, and proper coverage. Nonran-
dom subject dropout can be accommodated by the nested g-formula, at least to the extent
to which the dropout is explainable by observable covariates. This gives the nested g-formula
approach an advantage over alternative approaches that do not account for this commonly
encountered limitation. Additionally, our approach showed relatively low sensitivity to de-
partures from distributional assumptions on the outcome in many settings.
One limitation of this approach is that parametric models must be specified to estimate
models of interest. This is quite important for cost outcomes which may, in practice, be
right skewed. This is of particular relevance when cost distributions differ between groups
but are presumed to be the same. However, the parametric assumptions made by the GLMs
used in the nested g-formula approach can be tested and separate models can be used for
the treatment groups. Moreover, we found that the Normal model was quite flexible even
in the presence of heavy right-skewness, suggesting a level of robustness with this simpler
approach. A more flexible modeling procedure to account for departures from distributional
assumptions in the nested g-formula could be of interest.
The nonparametric bootstrap performed well in representing the true repeat-sample vari-
ability. When hypothesis testing is the primary goal, Wald-type tests based on the nonpara-
metric bootstrap standard errors have been suggested to have somewhat lower power than
alternatives (Davison and Hinkley, 1997). The parametric bootstrap test has been proposed,
whereby a null model is fit and data are repeatedly simulated from the null parameters.
The results from those simulated data sets are compared to the unconstrained estimator in
question. While this approach could potentially be applicable, it would require specification
of the treatment and censoring models, each of which is bypassed in the nested g-formula.
Such an approach could also prove computationally taxing. In addition to finding ways to
relax distributional and parametric assumptions with more flexible modeling, it would be of
interest to compare or develop more optimal hypothesis testing procedures.
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Appendix A: Derivation of the parametric nested g-formula.
We can write the mean potential cost by sequentially invoking the tower property of expec-
tation. Iterating out observations in interval j − 1 yields the following expression:
E[Y a¯j ] = EY¯j−1,D¯j−1,C¯j=0,L¯j ,A¯j=a¯j [E0[Yj]]
= EL¯j−1,A¯j−1=a¯j−1,Y¯j−1,D¯j−1,C¯j−1=0 [E1 [E0[Yj]]]
= ED¯j−2,C¯j−1=0,L¯j−1,A¯j−1=a¯j−1,Y¯j−1 [E2 [E1 [E0[Yj]]]]
= EY¯j−2,D¯j−2,C¯j−1=0,L¯j−1,A¯j−2=a¯j−2 [E3 [E2 [E1 [E0[Yj]]]]] ,
where we define E0[·] ≡ EYj [·|Y¯j−1, D¯j−1, C¯j = 0, L¯j, A¯j = a¯j], E1[·] ≡ ELj [·|L¯j−1, A¯j−1 =
a¯j−1, Y¯j−1, D¯j−1, C¯j−1 = 0], E2[·] ≡ EDj−1 [·|D¯j−2, C¯j−1 = 0, L¯j−1, A¯j−1 = a¯j−1, Y¯j−1], and
E3[·] ≡ EYj−1 [·|Y¯j−2, D¯j−2, C¯j−1 = 0, L¯j−1, A¯j−2 = a¯j−2]. Iteration can be continued in this
way sequentially and reduced to the following expression:
E[Y a¯j ] =
∫∫∫
E[Yj|L¯j = ¯`j, A¯j = a¯j, Y¯j−1 = y¯j, D¯j = d¯j, C¯j = 0]
×
j−1∏
k=1
fYk|Y¯k−1,C¯k,L¯k,A¯k,D¯k−1(yk, y¯k−1, 0,
¯`
k, a¯k, d¯k−1)
×
j∏
k=1
fDk|D¯k−1,Y¯k,C¯k,L¯k,A¯k(dk, d¯k−1, y¯k, 0,
¯`
k, a¯k)
×
j∏
k=1
fLk|L¯k−1,A¯k−1,D¯k−1,Y¯k−1,C¯k(`k,
¯`
k−1, a¯k−1, d¯k−1, y¯k−1, 0)dd¯jdy¯jd¯`j.
Noting that the conditional expectation of Yj can be parametrically expressed, we have:
E[Y a¯j ] =
∫∫∫
yj
j∏
k=1
fYk|Y¯k−1,C¯k,L¯k,A¯k,D¯k−1(yk, y¯k−1, 0,
¯`
k, a¯k, d¯k−1)
×
j∏
k=1
fDk|D¯k−1,Y¯k,C¯k,L¯k,A¯k(dk, d¯k−1, y¯k, 0,
¯`
k, a¯k)
×
j∏
k=1
fLk|L¯k−1,A¯k−1,D¯k−1,Y¯k−1,C¯k(`k,
¯`
k−1, a¯k−1, d¯k−1, y¯k−1, 0)dd¯jdy¯jd¯`j.
Writing E[Y a¯] = ∑Jj=1 E[Y a¯j ], we have the desired result.
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Appendix B: Summary of fixed simulation parameters.
Scenario Model Description Parameter Value
(α0,1, σ
2
L1
) Baseline confounder (0, 1)
(η0,1, η1,1) Baseline treatment probability (0, 1)
(β0,1, β1,1, β2,1) Baseline mean cost (20, 1, 2)
(γ0,1, γ1,1, γ2,1) Death probability after first interval (−5, 0.3, 0.05)
(α0, . . . , α3, σ
2
L) Follow-up confounder (−1.09, 0.5, 0.5, 0.04, 4)
(η0, . . . , η4) Follow-up treatment probability (−1.34, 0.4, 0.6, 1, 0.04)
(β0, . . . , β5) Follow-up mean cost (10.65, 0.2, 0.4, 0.2, 0.4, 0.05)
(γ0, . . . , γ3) Follow-up probability of death (−3, 0.1, 0.2, 0.03)
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Appendix C: Review of Inverse-Weighting Approaches for ITT Effects
We review the weighting approach of Lin (2000) and the IPTW-based extension discussed
by Li et al. (2016) to address censoring in the analysis of cost data.
C.1: Notation
Let i = 1, . . . , N index study subjects, and let 0 ≡ τ0 < τ1 < · · · < τJ−1 < τJ ≡ τ
denote a discrete partition of the time interval of interest. Again let Yij denote the cost in
interval [τj−1, τj), and Yi =
∑J
j=1 Yij the cumulative cost over [0, τ ]. Define Ai to be baseline
treatment, and Li the set of baseline confounders for subject i. Let T
C
i and T
D
i denote the
censoring and survival times for subject i, respectively, and Ti = min{TDi , τ}. Further let
δi = 1(T
C
i ≥ Ti) denote the indicator of observing complete cost data for subject i. Finally,
let Xi = min{TDi , TCi }, and δ˜i = 1(TCi ≥ TDi ) the indicator of observing death for subject i.
C.2: The partitioned IPCW estimator
Lin (2000) proposed inverse-weighted equation to estimate the intent-to-treat effect ∆ITT ≡
E[Yi|Ai = 1,Li] − E[Yi|Ai = 0,Li]. Let K̂(t) denote the Kaplan-Meier estimator of K(t) =
P (TC > t) based on {(Xi, 1− δ˜i) : i = 1, . . . , N}. A Z-estimator ∆̂ can be obtained through
the following estimating equations:
∑
i|δi=1
W i(Yi −W Ti ζ)
K̂(Ti)
= 0, (3)
where W i = (1, Ai,Li)
T , and ζ = (µ0,∆ITT, ζ1)
T ; here, ζ1 corresponds to confounders. Only
complete cases contribute to the estimating equations (all subjects contribute to the weights).
Recognizing the problem of efficiency loss associated with heavy censoring, Lin (2000)
then proposed the use of interval cost information to allow censored subjects to contribute
to the estimation of ∆ITT for as many intervals as they are not censored. In particular, let
Tij = min(T
D
i , τj) and δij = 1(T
C
i ≥ Tij). Then ∆j, the difference in mean cost between
the two treatment groups within interval j, can be estimated from the following estimating
equations, for j = 1, . . . , J :
∑
i|δij=1
W i(Yij −W Ti ζj)
K̂(Tij)
= 0, (4)
where ζj = (µ0j,∆
(j)
ITT, ζ1j)
T . Using the resulting estimators from these J estimating equa-
tions, we can estimate the difference in mean total cost by ∆̂ITT =
∑J
j=1 ∆̂
(j)
ITT.
These estimating equations result in closed-form expressions for ∆̂ and enjoy both con-
sistency and asymptotic normality under suitable regularity conditions. Sandwich-based
variance estimators suitable for weighted Z-estimators can be used to construct confidence
intervals and conduct inference. Of note, the Cox Proportional Hazards model can be used
to estimate K̂(t) if one wishes to condition on baseline observable covariates.
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C.3: Propensity score adjustment
Li et al. (2016) proposed (among other forms of propensity score adjustment) an extension
to include IPTW-based weights. Confounding can therefore be addressed without altering
the target of inference (i.e., without needing a conditional model for mean cost). Let pii =
pii(Li) = P (Ai = 1|Li); it is standard to estimate propensity scores pii by obtaining predictions
from a logistic regression model. First, an estimate of (ψ0,ψ) is obtained from the model
logit(pii) = ψ0+L
T
i ψ using, for example, maximum likelihood. In turn, predicted probabilities
can be obtained: pˆii = exp(ψˆ0 + L
T
i ψˆ)/[1 + exp(ψˆ0 + L
T
i ψˆ)].
Weights can be incorporated into the equations of the IPCW estimator to estimate ∆ITT.
For example, ∆̂
(j)
ITT from the partition approach could be obtained by solving the estimating
equations
∑
i|δij=1
W i(Yij −W Ti ζj)
K̂(Tij)
·
[
Ai
pii
+
1− Ai
1− pii
]
= 0. (5)
The estimator ∆̂ITT has a closed-form expression and, too, is asymptotically normal and
consistent under weight positivity and correct propensity score model specification.
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